First Time Loading...

Dr. Lal PathLabs Ltd
NSE:LALPATHLAB

Watchlist Manager
Dr. Lal PathLabs Ltd Logo
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Watchlist
Price: 2 308.5 INR -1.78%
Updated: May 3, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Dr. Lal PathLabs Ltd

Revenue
21.7B INR
Cost of Revenue
-4.5B INR
Gross Profit
17.2B INR
Operating Expenses
-12.9B INR
Operating Income
4.4B INR
Other Expenses
-1.1B INR
Net Income
3.3B INR

Margins Comparison
Dr. Lal PathLabs Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
191.8B INR
79%
20%
15%
US
Cigna Group
XMUN:CGN
98.9B EUR
13%
5%
3%
US
Cigna Corp
NYSE:CI
100.8B USD
13%
5%
3%
US
CVS Health Corp
NYSE:CVS
71B USD
15%
4%
2%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8B EUR
23%
5%
-3%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD
28%
9%
4%
US
Quest Diagnostics Inc
NYSE:DGX
15.1B USD
33%
14%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR
25%
7%
3%
US
DaVita Inc
NYSE:DVA
12.6B USD
31%
13%
6%
DE
Fresenius Medical Care AG
XMUN:FME
11.5B EUR
25%
7%
3%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
4%
-22%
-24%
Country IN
Market Cap 191.8B INR
Gross Margin
79%
Operating Margin
20%
Net Margin
15%
Country US
Market Cap 98.9B EUR
Gross Margin
13%
Operating Margin
5%
Net Margin
3%
Country US
Market Cap 100.8B USD
Gross Margin
13%
Operating Margin
5%
Net Margin
3%
Country US
Market Cap 71B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country DE
Market Cap 15.8B EUR
Gross Margin
23%
Operating Margin
5%
Net Margin
-3%
Country US
Market Cap 16.9B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country US
Market Cap 15.1B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 11.8B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 12.6B USD
Gross Margin
31%
Operating Margin
13%
Net Margin
6%
Country DE
Market Cap 11.5B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 9.5B USD
Gross Margin
4%
Operating Margin
-22%
Net Margin
-24%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Dr. Lal PathLabs Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
191.8B INR
20%
14%
23%
22%
US
Cigna Group
XMUN:CGN
98.9B EUR
11%
3%
9%
7%
US
Cigna Corp
NYSE:CI
100.8B USD
11%
3%
9%
7%
US
CVS Health Corp
NYSE:CVS
71B USD
11%
3%
9%
6%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8B EUR
-3%
-1%
2%
1%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD
5%
2%
7%
4%
US
Quest Diagnostics Inc
NYSE:DGX
15.1B USD
13%
6%
11%
8%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR
4%
1%
4%
3%
US
DaVita Inc
NYSE:DVA
12.6B USD
78%
4%
11%
8%
DE
Fresenius Medical Care AG
XMUN:FME
11.5B EUR
4%
1%
4%
3%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
-26%
-41%
-35%
Country IN
Market Cap 191.8B INR
ROE
20%
ROA
14%
ROCE
23%
ROIC
22%
Country US
Market Cap 98.9B EUR
ROE
11%
ROA
3%
ROCE
9%
ROIC
7%
Country US
Market Cap 100.8B USD
ROE
11%
ROA
3%
ROCE
9%
ROIC
7%
Country US
Market Cap 71B USD
ROE
11%
ROA
3%
ROCE
9%
ROIC
6%
Country DE
Market Cap 15.8B EUR
ROE
-3%
ROA
-1%
ROCE
2%
ROIC
1%
Country US
Market Cap 16.9B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country US
Market Cap 15.1B USD
ROE
13%
ROA
6%
ROCE
11%
ROIC
8%
Country DE
Market Cap 11.8B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 12.6B USD
ROE
78%
ROA
4%
ROCE
11%
ROIC
8%
Country DE
Market Cap 11.5B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 9.5B USD
ROE
464%
ROA
-26%
ROCE
-41%
ROIC
-35%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More